Longeveron (LGVN) Prepaid Assets (2021 - 2026)
Longeveron (LGVN) recorded quarterly Prepaid Assets of $1.0 million in Q1 2026, up 50.0% quarter-over-quarter from $686000.0 in Q4 2025, and up 11.97% on a YoY basis from $919000.0 in Q1 2025.
Longeveron (LGVN) Prepaid Assets (2021 - 2026) Analysis & Trends
Longeveron's Prepaid Assets history runs 6 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 11.97% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 11.97% YoY), while the FY2025 annual figure was $686000.0, up 122.73% from the prior year.
- Prepaid Assets was $1.0 million for Q1 2026 at Longeveron, up from $686000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.5 million in Q2 2023 to a low of $308000.0 in Q4 2024.
- Historically, Prepaid Assets has averaged $859642.9 across 5 years, with a median of $911500.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets slumped 46.91% in 2024, then surged 122.73% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $404000.0 in 2022, then declined by 6.93% to $376000.0 in 2023, then declined by 18.09% to $308000.0 in 2024, then soared by 122.73% to $686000.0 in 2025, then surged by 50.0% to $1.0 million in 2026.
- The last three Prepaid Assets figures came in at $1.0 million (Q1 2026), $686000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 686,000.00 |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 904,000.00 |
| Mar 31, 2025 | 919,000.00 |
| Dec 31, 2024 | 308,000.00 |
| Sep 30, 2024 | 609,000.00 |
| Jun 30, 2024 | 817,000.00 |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 404,000.00 |
| Dec 31, 2021 | 282,000.00 |